Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8335735 | 0.74 | — | — | |
| SCHEMBL5350171 | 0.71 | LMNA (0.41) | TSHRHSD17B10 | |
| SCHEMBL9575751 | 0.68 | TSHR (0.32) | TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL7415459 | 0.67 | ALDH1A1 (0.36) | — | |
| SCHEMBL10888143 | 0.64 | ALDH1A1 (0.30) | HSD17B10 | |
| SCHEMBL8637321 | 0.62 | TSHR (0.33) | TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL7600368 | 0.62 | TSHR (0.33) | TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL11904680 | 0.60 | TSHR (0.36) | TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL262994 | 0.59 | PYGM (0.35) | — | |
| SCHEMBL19750859 | 0.59 | TSHR (0.35) | TSHRMAPK1HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2582665-A1 | AN IMPROVED PROCESS FOR PREPARATION OF AMISULPRIDE | Lupin Limited (IN) | 2013-04-24 | — | — | EP | disclosed |
| US-20130096319-A1 | PROCESS FOR PREPARATION OF AMISULPRIDE | LUPIN LIMITED (IN) | 2013-04-18 | — | — | US | disclosed |
| WO-2011158084-A1 | AN IMPROVED PROCESS FOR PREPARATION OF AMISULPRIDE | LUPIN LIMITED (IN) | 2011-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130096319-A1 | PROCESS FOR PREPARATION OF AMISULPRIDE | TST, TPMT, MSRB3 | TSHR 679/4885MAPK1 2837/4885HSD17B10 1639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.